Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Filana Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$28.70M. For fiscal 2025 it was -$32.25M. The highest annual figure on record is -$143.00K in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$32.25M | – |
| FY2024 | Dec 31, 2024 | -$116.93M | – |
| FY2023 | Dec 31, 2023 | -$82.03M | – |
| FY2022 | Dec 31, 2022 | -$77.51M | – |
| FY2021 | Dec 31, 2021 | -$30.20M | – |
| FY2020 | Dec 31, 2020 | -$5.38M | – |
| FY2019 | Dec 31, 2019 | -$2.51M | – |
| FY2018 | Dec 31, 2018 | -$4.77M | – |
| FY2017 | Dec 31, 2017 | -$8.24M | – |
| FY2016 | Dec 31, 2016 | -$12.23M | – |
| FY2015 | Dec 31, 2015 | -$9.05M | – |
| FY2014 | Dec 31, 2014 | -$9.55M | – |
| FY2013 | Dec 31, 2013 | -$6.95M | – |
| FY2012 | Dec 31, 2012 | -$7.17M | – |
| FY2011 | Dec 31, 2011 | -$260.00K | – |
| FY2010 | Dec 31, 2010 | -$143.00K | – |
| FY2009 | Dec 31, 2009 | -$14.69M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.88M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.22M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.95M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.34M | – |
| Q4 FY2024 | Dec 31, 2024 | -$61.27M | – |
| Q3 FY2024 | Sep 30, 2024 | -$18.30M | – |
| Q2 FY2024 | Jun 30, 2024 | -$18.24M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.13M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.32M | – |
| Q3 FY2023 | Sep 30, 2023 | -$26.53M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.92M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.26M | – |
| Q4 FY2022 | Dec 31, 2022 | -$21.32M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.55M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.11M | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.53M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.76M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.14M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.18M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$842.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.19M | – |
| Q4 FY2019 | Dec 31, 2019 | -$589.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$730.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$591.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$604.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$565.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.44M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.13M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.64M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.44M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.15M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.20M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.45M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.03M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.79M | – |
See a number that looks wrong?